Conventional hematotoxicity testing involves measuring different mature blood-cell components, over time after administation of an agent. For proliferating systems, major toxicity does not occur in mature cells but in the cells responsible for producing the mature cells, namely the stem and progenitor cells for the lymphohematopoeitic system.For stem cell hemotoxicity to play a role at all stages of drug development, the HALO ( Hematopoeitic/hematotoxicity Assays via Luminescence Output), was developed. Does anyone know the name of company/ies that provide Halo platforms?
Do you mean these guys?http://www.hemogenix.com/index2.php
Board Rules | Advertise | Privacy | Mobile Feed
© 2004-2008 Scientist Solutions, All Rights Reserved.Resources from NCBI used on this site.